Scott Warren

With over 20 years of experience in wealth management and the stock market, I specialize in identifying high-growth opportunities while maintaining strict risk

[Scott Warren @ScottWarren4852]

If you’re looking for a place to discuss U.S. stock opportunities every day, feel free to join our WhatsApp stock group. WhatsApp:
https://t.co/m048wdgcSs
The group primarily shares: • Intraday trading opportunities • Medium- to long-term stock research • Market highlights and industry trends • Individual stock analysis and trading strategies Our screening criteria focus on stocks with 30%+ potential upside, but market risks remain, and returns are not guaranteed. Add Moore and send “3” to receive a free group invitation. Investing isn’t a solo battle—let’s exchange ideas and grow together.
#NVDA #MSFT #MU #AVGO #TSLA #AMZN #GOOGL #CIFR

[Scott Warren @ScottWarren4852]

$TLSI: riSalus develops interventional drug delivery catheters for liver cancer: using pressure to deliver drugs into tumor vessels, minimizing leakage into normal tissue. The older TriNav is already on the market; Advance addresses this by using thinner, more distal, and more complex blood vessels, and can be paired with microcatheters chosen by the physician. The company says it will have a limited rollout in the coming weeks. Full-year guidance remains at $54-$57 million. Q2 revenue of $11.41 million exceeded expectations, but it is still operating at a loss.

Customs clearance was delayed by about five months, and the market had already factored in the "new product" from expectations. The sudden arrival of this late-arriving product caused short sellers and those on the sidelines to change their tune overnight. Adding a layer of CMS G-code, and expanding reimbursement from hospitals to outpatient laboratories, makes the sales path slightly stronger than a pure medical device story.

This is a small-cap medical device company with a market capitalization of approximately $300 million, still operating at a significant loss in TTM, with short sellers holding about 9.6% of the outstanding shares. Customs clearance does not equate to large-scale sales. The company itself describes it as a limited market release. The price fell from $5.84 to around $5.57 pre-market, indicating that some investors have already taken profits at the gap. The 52-week high of $7.95 represents a year-to-date decline of approximately 29%.

Short-term (3–10 trading days)

Bullish: A close above $5.70 would target $6.50, followed by $7.20–$7.50.

Baseline: The clearance premium will be absorbed within the $5.00–$**** range.

Weak: A drop back to $****–$*** would indicate the event is fully priced in, returning to the pre-clearance range.

For more information, follow me or add me as a friend. I will send you the latest updates daily.

#NVDA #MU #META #AMD #SNDK #TLSI #RKLB

[Scott Warren @ScottWarren4852]

Meta Climbs Over 4% on AI Gadget Momentum
Meta Platforms rose more than 4.5%, one of the strongest performers among mega-cap tech. The gain followed the recent launch of its Muse AI assistant and the unveiling of a new palm-sized hardware device designed to work with the AI product. Investor enthusiasm for the company’s AI strategy helped offset broader market caution.
#Meta #AIAssistant #TechGains #SocialMedia #AIHardware #Innovation #MegaCap

[Scott Warren @ScottWarren4852]

Friday setup, three names only: $ASTS, $IREN, $NKE.$ASTS — constellation is building, U.S. service slipped to 2027, stock got hit. That’s when this ticker gets loud again.
$IREN — power + AI contracts are the asset. Multiple compressed from the highs. AI infra still trades every headline.
$NKE — beaten-up mega-brand, targets still sit well above $36. Mean-reversion candidate if consumer tape firms.Advantage: one space name, one AI-power name, one liquid consumer. You can actually get https://t.co/ONtm09F5rX this. Follow for the open checklist. Group gets the invalidation levels I won’t put on the main timeline.
#ASTS #Satellite #IREN #AIInfrastructure #Nike #Consumer #SpaceStocks

[Scott Warren @ScottWarren4852]

$SKYQ +24% Missed this move? Don't chase yesterday's winner. Keep an eye out for tomorrow's setup. Every day, I curate a list of stocks to watch, key catalysts, and market trends. Want to join my WhatsApp group? Profile → WhatsApp → Send "3" Let's find the next opportunity worth watching together.
#NVIDIA #MU #SNDK #AMD #AI #Semiconductors #Memory

[Scott Warren @ScottWarren4852]

Some opportunities are better discussed in a focused environment rather than posted publicly. Today’s private watchlist includes:

$S *** I’m sharing the full analysis with my private group members first. The setup includes: Entry → Risk → Momentum → Exit Members will have access to a reference entry range, defined risk level, intraday updates and potential exit signals. The stock could experience 10%–40% intraday movement under the right market conditions, which also means elevated risk. If you want access to the same stock information: Add my WhatsApp through the number on my profile. Send me a message after adding me. I’ll share the information that was posted in the group. Private research. Clear levels. Your decision.
#Stock #StockMarket #NVDA #MSFT #MU #AVGO #TSLA #AMZN

[Scott Warren @ScottWarren4852]

Some opportunities are better discussed in a focused environment rather than posted publicly. Today’s private watchlist includes:

$S *** I’m sharing the full analysis with my private group members first. The setup includes: Entry → Risk → Momentum → Exit Members will have access to a reference entry range, defined risk level, intraday updates and potential exit signals. The stock could experience 10%–40% intraday movement under the right market conditions, which also means elevated risk. If you want access to the same stock information: Add my WhatsApp through the number on my profile. Send me a message after adding me. I’ll share the information that was posted in the group. Private research. Clear levels. Your decision.
#Stock #StockMarket #NVDA #MSFT #MU #AVGO #TSLA #AMZN

[Scott Warren @ScottWarren4852]

$REI: An onshore U.S. exploration and production (E&P) company operating primarily in the Central Basin Platform (CBP) and Northwest Shelf of Texas. Its assets are characterized as "conventional, shallow-decline, and long-life" rather than the ultra-high-capital-intensity shale plays typical of the Delaware Basin. Cash flow is driven by oil prices, realized pricing, the impact of natural gas/condensate economics, drilling cadence, and the cost of debt.

Product and Operational Highlights
Product Mix: Predominantly crude oil (accounting for approximately 60% of production), with the remainder consisting of NGLs and natural gas. Q2 average daily sales volume was approximately 19,990 Boe/d, including roughly 12,683 Bopd of crude oil.
Asset Characteristics: Management emphasizes shallow decline rates, high Net Revenue Interest (NRI), stacked pay zones, and the capability to drill 1.5–2 mile horizontal wells. The company claims a drilling inventory exceeding 10 years with over 500 identified well locations; 1P reserves stand at approximately 153 million barrels of oil equivalent (MMBoe), with a PV-10 value of roughly $1.32 billion (based on company data).
Operational Profile: Consistently positive operating cash flow over multiple years; leverage is approximately 1.7x (quarterly annualized), with a target to reduce this below 1.25x. The borrowing base has been reaffirmed, and the company has a track record of debt repayment. It is one of the leading independent producers on the Texas side of the CBP.
Technical Approach: Applies horizontal drilling, extended lateral lengths, and stacked-pay development to conventional reservoirs, distinguishing it from the "factory-style" drilling typical of pure-play shale operations. This approach represents both a key differentiator and a potential execution risk. Q2 2026: Revenue of approximately $104.7 million (realized oil price of ~$95.45/bbl)
Adjusted net income of ~$24 million ($0.10/share), a significant quarter-over-quarter increase
Adjusted EBITDA of ~$54.5 million, up ~42% quarter-over-quarter
LOE of ~$10.12/Boe; total cash operating costs of ~$21.59/Boe
Drilled 7 wells and completed 4 wells during the quarter (including the Yoakum horizontal well)

H2 2026 outlook: Crude oil 13,000–13,950 Bopd; total production 20,600–21,800 Boe/d; capital expenditure $80–$100 million
Full-year capital expenditure of ~$158–$178 million (increased from initial guidance to pave the way for 2027 production)
2027 preliminary outlook: Total production 21,500–23,500 Boe/d (up ~10%); capital expenditure $135–$165 million

12-month price target: $2.00

If you are interested in in-depth stock analysis, catalysts, and key price levels, please follow me or add me as a friend. I regularly publish further research and insights.
#MU #META #MCD #NVDA #PLTR #GME #SOFI

[Scott Warren @ScottWarren4852]

$REI — Permian producer leaning on 2027 growth, not a new headline today
Ring Energy’s live file is still the Aug 6 Q2: revenue $104.7M, adjusted EBITDA $54.5M, sales 19,990 Boe/d, oil 12,683 Bopd, leverage ~1.7x. 2H26 oil guide 13,000–13,950 Bopd. Initial 2027 output 21,500–23,500 Boe/d (~10% growth) on lower capex. Mizuho started Neutral at $2; BofA has Buy at $2. Stock ~$1.33, cap ~$347M. No fresh operational release this week. The next hard date is the Nov 5 print. Oil price remains the daily driver.
#REI #Permian #Oil #EandP #Energy #WTI #SmallCaps

[Scott Warren @ScottWarren4852]

Intel is the most argued semiconductor under $200 right now: foundry hope on one side, execution scars on the other. That is exactly why it stays in the daily discussion. Pair it with $SMCI if the AI-server debate is still live, and $CSCO if the market wants a cheaper networking/AI-capex proxy after the mega-caps slipped. All three were in this week’s volume and comment stacks. A bounce in “unloved but talked-about” chips often shows up before Nvidia cousins get a clean green day.
The levels and the bear case are both in the group. Follow the profile if you want both, not only the bull slide.
#IntelTurnaround #AIServers #NetworkingGear #ChipDebate #VolumeLeaders #YieldPressure #SectorRepair

[Scott Warren @ScottWarren4852]

$SMJF +25% Missed this move? Don't chase yesterday's winner. Keep an eye out for tomorrow's setup. Every day, I curate a list of stocks to watch, key catalysts, and market trends. Want to join my WhatsApp group? Profile → WhatsApp → Send "3" Let's find the next opportunity worth watching together.
#NVIDIA #MU #SNDK #AMD #AI #Semiconductors #Memory

[Scott Warren @ScottWarren4852]

Some opportunities are better discussed in a focused environment rather than posted publicly. Today’s private watchlist includes:

$S
*** I’m sharing the full analysis with my private group members first. The setup includes: Entry → Risk → Momentum → Exit Members will have access to a reference entry range, defined risk level, intraday updates and potential exit signals. The stock could experience 10%–40% intraday movement under the right market conditions, which also means elevated risk. If you want access to the same stock information: Add my WhatsApp through the number on my profile. Send me a message after adding me. I’ll share the information that was posted in the group. Private research. Clear levels. Your decision.
#Stock #StockMarket #NVDA #MSFT #MU #AVGO #TSLA #AMZN

[Scott Warren @ScottWarren4852]

@Quant_MarketPro Exactly. Clearance removes the regulatory hurdle, but real validation comes from adoption. I’d watch revenue growth, procedure volume, and whether TriNav Advance can scale without materially increasing losses.

[Scott Warren @ScottWarren4852]

$TLSI: riSalus develops interventional drug delivery catheters for liver cancer: using pressure to deliver drugs into tumor vessels, minimizing leakage into normal tissue. The older TriNav is already on the market; Advance addresses this by using thinner, more distal, and more complex blood vessels, and can be paired with microcatheters chosen by the physician. The company says it will have a limited rollout in the coming weeks. Full-year guidance remains at $54-$57 million. Q2 revenue of $11.41 million exceeded expectations, but it is still operating at a loss.

Customs clearance was delayed by about five months, and the market had already factored in the "new product" from expectations. The sudden arrival of this late-arriving product caused short sellers and those on the sidelines to change their tune overnight. Adding a layer of CMS G-code, and expanding reimbursement from hospitals to outpatient laboratories, makes the sales path slightly stronger than a pure medical device story.

This is a small-cap medical device company with a market capitalization of approximately $300 million, still operating at a significant loss in TTM, with short sellers holding about 9.6% of the outstanding shares. Customs clearance does not equate to large-scale sales. The company itself describes it as a limited market release. The price fell from $5.84 to around $5.57 pre-market, indicating that some investors have already taken profits at the gap. The 52-week high of $7.95 represents a year-to-date decline of approximately 29%.

Short-term (3–10 trading days)

Bullish: A close above $5.70 would target $6.50, followed by $7.20–$7.50.

Baseline: The clearance premium will be absorbed within the $5.00–$**** range.

Weak: A drop back to $****–$*** would indicate the event is fully priced in, returning to the pre-clearance range.

For more information, follow me or add me as a friend. I will send you the latest updates daily.

#NVDA #MU #META #AMD #SNDK #TLSI #RKLB

[Scott Warren @ScottWarren4852]

Some opportunities are better discussed in a focused environment rather than posted publicly. Today’s private watchlist includes:

$S
*** I’m sharing the full analysis with my private group members first. The setup includes: Entry → Risk → Momentum → Exit Members will have access to a reference entry range, defined risk level, intraday updates and potential exit signals. The stock could experience 10%–40% intraday movement under the right market conditions, which also means elevated risk. If you want access to the same stock information: Add my WhatsApp through the number on my profile. Send me a message after adding me. I’ll share the information that was posted in the group. Private research. Clear levels. Your decision.
#Stock #StockMarket #NVDA #MSFT #MU #AVGO #TSLA #AMZN

[Scott Warren @ScottWarren4852]

$TLSI — FDA clearance, limited launch
TriSalus received 510(k) clearance for TriNav Advance, a pressure-enabled device aimed at small distal vessels in liver embolization. Shares closed $4.93 and jumped about 13%–17% pre-market. A limited U.S. release starts in the coming weeks. H.C. Wainwright moved its target to $12. Full-year sales guide remains $54–$57 million. The trade now shifts from approval to hospital uptake.
#TriNavAdvance #FDANews #OncologyMedtech #DeviceClearance #LimitedLaunch #Wainwright #MicrocapHealth

[Scott Warren @ScottWarren4852]

@StockSavvyShay “Interesting move. $MU and $NBIS are now on the radar—let’s see whether Burry’s thesis plays out.

[Scott Warren @ScottWarren4852]

Tomorrow's Picks: $NVDA, $AVGO, $TSLA
Key Strengths:
$NVDA: Solid core position in AI
$AVGO: Beneficiary across the semiconductor supply chain
$TSLA: Dual catalysts from robotics and AI Let the data do the talking—keep an eye on these three tomorrow. Follow me for daily top picks and join the group to track real-time trades.
#NVIDIA #Broadcom #Tesla #AIHardware #Robotics #GrowthStocks #MarketMovers

[Scott Warren @ScottWarren4852]

$SPRO +20% Missed this move? Don't chase yesterday's winner. Keep an eye out for tomorrow's setup. Every day, I curate a list of stocks to watch, key catalysts, and market trends. Want to join my WhatsApp group? Profile → WhatsApp → Send "3" Let's find the next opportunity worth watching together.
#NVIDIA #MU #SNDK #AMD #AI #Semiconductors #Memory

[Scott Warren @ScottWarren4852]

Some opportunities are better discussed in a focused environment rather than posted publicly. Today’s private watchlist includes:

$S *** I’m sharing the full analysis with my private group members first. The setup includes: Entry → Risk → Momentum → Exit Members will have access to a reference entry range, defined risk level, intraday updates and potential exit signals. The stock could experience 10%–40% intraday movement under the right market conditions, which also means elevated risk. If you want access to the same stock information: Add my WhatsApp through the number on my profile. Send me a message after adding me. I’ll share the information that was posted in the group. Private research. Clear levels. Your decision.
#Stock #StockMarket #NVDA #MSFT #MU #AVGO #TSLA #AMZN

[Scott Warren @ScottWarren4852]

@MarioNawfal Those who control the entire technology stack operate on a different timeline.
If things actually proceed at this pace, it will cause long-term disruption for on-premise data centers and traditional cloud providers.

[Scott Warren @ScottWarren4852]

Some opportunities are better discussed in a focused environment rather than posted publicly. Today’s private watchlist includes:

$S *** I’m sharing the full analysis with my private group members first. The setup includes: Entry → Risk → Momentum → Exit Members will have access to a reference entry range, defined risk level, intraday updates and potential exit signals. The stock could experience 10%–40% intraday movement under the right market conditions, which also means elevated risk. If you want access to the same stock information: Add my WhatsApp through the number on my profile. Send me a message after adding me. I’ll share the information that was posted in the group. Private research. Clear levels. Your decision.
#Stock #StockMarket #NVDA #MSFT #MU #AVGO #TSLA #AMZN

[Scott Warren @ScottWarren4852]

$NBIS: The current competition isn't about who has the most impressive cluster architecture, but rather who can deliver power and GPU capacity on schedule. Customers unable to wait for 2027–2028 capacity are willing to pay $40–50 million per megawatt for immediate power access, whereas standard 1–3 year contracts hover around $20–25 million/MW. Visibility extends roughly 18–24 months, with sales conversations already shifting toward 2028 capacity.

The customer mix follows a leveraged structure: high-priced, medium-term orders from AI-native enterprises on one end, and massive, low-risk, long-term contracts from Microsoft and Meta on the other, layered with short-term, high-premium spot deals. Palantir is integrating underlying compute power with enterprise distribution and its "Token Factory," resulting in more substantial contracts and longer terms. With the Vineland, New Jersey zoning approval secured, Bloom Energy is bolstering the narrative around power supply and community integration. Regulatory hurdles represent an industry-wide supply constraint, not a scandal specific to Nebius alone.

Q2 group revenue hit $582 million, up 454% year-over-year; core cloud margins are around 50%; the backlog exceeds $40 billion, with approximately $9 billion in prepayments. Full-year guidance projects revenue of $3.0–3.4 billion, year-end ARR of $7.0–9.0 billion, and CapEx of $20.0–25.0 billion. After pulling back more than 20% from its peak, the stock closed Monday at $232.80, up 4.1%. High growth, high volatility, and high expenditure—all three characteristics coexist here.

The reasonable trading range for today is $225–245, with a higher probability of consolidating Monday's gains between $228 and $238; do not assume the pre-market level near $233 is a guaranteed breakout point. In the short term (1–2 weeks), if sector sentiment remains bullish and no new noise regarding power or community issues arises, the stock could test the $245–255 range; conversely, if concerns over equity dilution or project approval delays intensify, a retest of the $210–220 range is possible.

It may take another 1.5 to 2 years for supply and demand to reach equilibrium—a timeline even management is hesitant to commit to definitively. Once efficiency surges, demand will be ratcheted up further; meanwhile, community opposition could slow down new projects. Pricing power remains in play, as do execution and dilution.
#NVDA #AMD #META #TSLA #AVGO #INTC #NBIS

[Scott Warren @ScottWarren4852]

$NBIS — Nebius Is Turning AI Infrastructure Into a Capital-Intensive Growth Story

$NBIS remains one of the more closely watched names in the AI infrastructure space.

Nebius has been aggressively building capacity to serve the growing demand for AI computing. The company recently announced a partnership with Palantir to deliver a complete sovereign AI stack to Palantir customers, adding another layer to its infrastructure strategy.

The capital requirements are substantial. Nebius recently closed a private offering of convertible senior notes generating approximately $5.75 billion in gross proceeds, following an earlier $775 million secured debt financing.

That creates a classic AI infrastructure trade-off: more capital can allow the company to build more capacity, but investors also need to watch leverage, dilution risk, utilization and the speed at which new infrastructure becomes revenue-generating.

The bullish argument is straightforward. AI demand is growing faster than available high-performance computing capacity in many markets, and Nebius is trying to position itself as a major independent AI cloud provider.

The risk is equally clear: building infrastructure is expensive, and demand forecasts must eventually translate into actual customer utilization and cash generation.

For $NBIS, the next chapter is likely to be measured by capacity deployment, customer commitments, utilization and revenue growth, not simply the excitement surrounding AI.

#Nebius #AICloud #Palantir #GPUCompute #CloudInfrastructure #DataCenterStocks #ArtificialIntelligence